On September 13, Finbold unveiled the latest insights into the enigmatic world of Michael Burry, the renowned ‘Big Short’ investor.
In the report, Finbold shed light on Burry’s recent strategic moves, including a notable $4.2 million investment in Geo Group (NYSE: GEO) — a stock that recently benefited from a bullish report by Citron Research.
Today, on September 14, we embark on a deeper exploration, delving into Burry’s top 10 portfolio holdings, gleaned from the most recent 13F filings.
Picks for you
What are Burry’s top 10 holdings at the moment?
Per data disclosed Michael Burry’s portfolio was valued at more than $1.73 billion, over 97% of which is captured by his top 10 investments.
As mentioned in the earlier reports, the bulk of the iconic investor’s portfolio is invested in his new ‘Big Short’ position, this time targeting the US stock market.
Notably, a month ago, it was disclosed that Burry shorted US equities by purchasing 40,000 put options contracts tied to SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ Trust (QQQ) – two major exchange-traded funds (ETFs).
The nominal value of these contracts is $1.6 billion and the two holdings account for over 93% of Burry’s portfolio, with SPY at 51% and QQQ at 42.5%.
SPY and QQQ both saw significant returns in 2023 at over 17% and 40%, respectively, which is not a favorable sign for Burry, considering that he shorted the two funds.
What are the other 8 stocks Burry invested in?
Apart from the two funds, other stocks that make up Burry’s top 10 holdings include Expedia Group, Expedia Group (NASDAQ: EXPE), Charter Communications (NASDAQ: CHTR), Generac Holdings (NYSE: GNRC), Cigna Corp., (NYSE: CI), CVS Health Group (NYSE: CVS), MGM Resorts (NYSE: MGM), Stellantis NV (NYSE: STLA), and Vital Energy (NYSE: VTLE).
All of these 8 positions account for less than 1% of Burry’s current portfolio, with a nominal value of more than $60,000, according to the latest 13F data.
The major portion of these stocks have positive returns this year, with most of them returning between 20% and 30% since January 1.
The only equity with negative year-to-date performance is Cigna, which saw its share price decline by around 11% in 2023.
Buy stocks now with Interactive Brokers – the most advanced investment platform
Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.
